Ultrasound-guided liver mass biopsy

Objective: This study aimed to present the histopathological results and demographic characteristics of patients who underwent an ultrasound-guided liver mass biopsy. Material and Methods: Medical information of patients who underwent a liver mass biopsy in the interventional radiology clinic between September 2016 and Septem- ber 2021 were retrieved retrospectively from the hospital data processing system and the interventional radiology archive. Baseline demographic characteristics of the patients and the technical success and the complication rate of the biopsy pro- cedure were investigated. Results: A total of 283 liver mass biopsies were performed on 162 women and 121 men, with a mean age of 52.3 years. All biopsies were performed under ultrasound guidance with an 18 gauge fully-automatic Tru-Cut biopsy needle. After the biopsy, the histopathological diagnosis was malignant in 95.4% (n=270) and benign in 4.5% (n=13) of the masses. The most common malignant diagnosis was breast cancer metastasis (25.8%) and the most common benign diagnosis were cirrhotic nodule (1.4%) and granulomatous inflammation (1.4%). The technical success rate was 100% in this study. The most common complications were a subcapsular hematoma (n=5) and pain (n=2). There was a significant relationship between subcapsular hematoma formation and the histopathological diagnosis (p

PDF

___

1. Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: Practical magnetic resonance imaging ap- proach. World J Hepatol 2015;7:1987–2008.
2. Galea N, Cantisani V, Taouli B. Liver lesion detection and character- ization: Role of diffusion-weighted imaging. J Magn Reson Imaging 2013;37:1260–76.
3. Oldhafer KJ, Habbel V, Horling K, Makridis G, Wagner KC. Benign liver tumors. Visc Med 2020;36:292–303.
4. Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: Comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999;213:86–91.
5. Namasivayam S, Martin DR, Saini S. Imaging of liver metastases: MRI. Cancer Imaging 2007;7:2–9.
6. Khalifa A, Rockey DC. The utility of liver biopsy in 2020. Curr Opin Gas- troenterol 2020;36:184–91.
7. Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 2020;69:1382–403.
8. Veltri A, Bargellini I, Giorgi L, Almeida PAMS, Akhan O. CIRSE guide- lines on percutaneous needle biopsy (PNB). Cardiovasc Intervent Ra- diol 2017;40:1501–13.
9. Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: Good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond) 2019;39:22.
10. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of co- agulation status and hemostasis risk in percutaneous image-guided in- terventions. J Vasc Interv Radiol 2012;23:727–36.
11. Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: Part I. Development, growth, and spread: Key pathologic and imaging aspects. Radiology 2014;272:635–54.
12. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangio- carcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:1198–203.
13. Chen VL, Sharma P. Role of biomarkers and biopsy in hepatocellular carcinoma. Clin Liver Dis 2020;24:577–90.
14. Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, D’Angelica MI, Endo I, et al. Liver metastases. Nat Rev Dis Primers 2021;7:27.
15. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, An- derson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70:145–64.
16. Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg 2019;3:50–6.
17. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49.
18. Xiao W, Zheng S, Yang A, Zhang X, Zou Y, Tang H, et al. Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: A popula- tion-based study. Cancer Manag Res 2018;10:5329–38.
19. Botteri E, Disalvatore D, Curigliano G, Brollo J, Bagnardi V, Viale G, et al. Biopsy of liver metastasis for women with breast cancer: Impact on survival. Breast 2012;21:284–8.
20. Schrijver WAME, Suijkerbuijk KPM, van Gils CH, van der Wall E, Moe- lans CB, van Diest PJ. Receptor conversion in distant breast cancer metastases: A systematic review and meta-analysis. J Natl Cancer Inst 2018;110:568–80.
21. Riihimäki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer 2014;86:78–84.
22. Horn SR, Stoltzfus KC, Lehrer EJ, Dawson LA, Tchelebi L, Gusani NJ, et al. Epidemiology of liver metastases. Cancer Epidemiol 2020;67:101760.
23. Golubnitschaja O, Sridhar KC. Liver metastatic disease: New concepts and biomarker panels to improve individual outcomes. Clin Exp Metas- tasis 2016;33:743–55.
24. Khalifa A, Sasso R, Rockey DC. Role of liver biopsy in assessment of radiologically identified liver masses. Dig Dis Sci 2022;67:337–43.
25. Anderson SW, Kruskal JB, Kane RA. Benign hepatic tumors and iatro- genic pseudotumors. Radiographics 2009;29:211–29.
26. Dreifuss NH, Ramallo D, McCormack L. Multifocal nodular fatty infiltra- tion of the liver: A rare benign disorder that mimics metastatic liver dis- ease. ACG Case Rep J 2021;8:e00537.
27. Yoshida T, Nishimori I, Kumon M, Kohsaki T, Taniuchi K, Ohtsuki Y, et al. Inflammatory pseudotumor of the liver: Report of a case diagnosed by needle biopsy. Hepatol Res 2003;27:83–6.
28. Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T. Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Part II. Minor and major complications and procedure-related mortality. Radiology 2013;266:226–35.
29. Mueller M, Kratzer W, Oeztuerk S, Wilhelm M, Mason RA, Mao R, et al. Percutaneous ultrasonographically guided liver punctures: An anal- ysis of 1961 patients over a period of ten years. BMC Gastroenterol 2012;12:173